Niihara Yutaka's Form 4 filing
Emmaus Life Sciences, Inc. (EMMA) · filed Dec 1, 2022
- Accession no.
- 0001209191-22-059154
- Filed
- Dec 1, 2022, 1:35 PM ET
- Trade date
- Nov 3-30, 2022
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $21.2K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Niihara YutakaCIK 0001517691 | Director, Officer (Chairman and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +2,500 | $0.45 | +$1,125 | 11,990,757 | Direct | |
| Nov 4, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +7,500 | $0.45 | +$3,375 | 11,998,257 | Direct | |
| Nov 28, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +5,000 | $0.35 | +$1,750 | 12,003,257 | Direct | |
| Nov 29, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +14,700 | $0.38 | +$5,586 | 12,017,957 | Direct | |
| Nov 30, 2022 | Common stock, $0.001 par value | PPurchaseAcquired | +22,900 | $0.41 | +$9,389 | 12,040,857 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.